regionalne fora eksperckie
Nowe europejskie zalecenia
dotyczące niewydolności serca
formuła hybrydowa
Dear friends and colleagues
On 27 August 2021, during the Congress of the European Society of Cardiology, the new European guidelines for the diagnosis and treatment of patients with heart failure (2021) will be announced and simultaneously published in the European Heart Journal and the European Journal of Heart Failure. This is one of the key expert documents in the field of cardiology, which has a tremendous impact on clinical practice in the area of heart failure care globally. It is a document that contains the guidelines based on scientific evidence concerning the diagnosis of heart failure and the use of established forms of comprehensive therapy in clinical practice, including new drugs, devices and procedures. Given the vast amount of key scientific data that has been published since the previous version of the guidelines (2016), it is reasonable to assume that the new document will differ significantly from the previous version.
In order to meet the expectations of cardiologists, cardiosurgeons, cooperating physicians of other specialties and other healthcare professionalists, and first of all havng in mind the benefits for our patients, we have decided to launch Academy of Heart Failure (Akademia Niewydolności Serca). The aim of this initiative will be to initiate and execute educational projects within the area of heart failure, to identify optimal solution for effective implementation of these guidelines for everyday clinical practice and to monitor of effectiveness of these activities in prospective registries and therapeutic programmes.
We would like to invite you cordially to join our projects!